Nkarta, Inc. (NKTX) shareholders
Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. Joint filing with Peter Kolchinsky (18.90%), Rajeev Shah (18.90%) and 1 more | 13,848,371 | 18.90% | 13D (active) amendment | Mar 27, 2024 |
| Boxer Asser Management Inc. Joint filing with Boxer Capital, LLC (9.00%), Joe Lewis (9.00%) | 4,407,350 | 9.00% | 13G (passive) | Jan 8, 2024 |
| Phillip Gross Joint filing with Adage Capital Management, L.P. (5.10%), Robert Atchinson (5.10%) | 3,600,000 | 5.10% | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NKTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 10,805,129 | 15.09% | $30.58M | – | 0.27% |
| BlackRock, Inc. | 6,300,212 | 8.80% | $17.83M | +1,791,739 | 0.00% |
| NEA Management Company, LLC | 3,568,781 | 4.98% | $10.10M | – | 0.64% |
| Samsara BioCapital, LLC | 3,507,666 | 4.90% | $9.93M | – | 0.82% |
| Sr One Capital Management, LP | 3,333,333 | 4.65% | $9.43M | – | 0.91% |
| GSK plc | 3,150,732 | 4.40% | $8.92M | – | 1.48% |
| Monaco Asset Management SAM | 2,373,400 | 3.31% | $6.72M | −148,532 | 0.53% |
| Vanguard Capital Management LLC | 2,226,415 | 3.11% | $6.30M | +214,994 | 0.00% |
| Citadel Advisors LLC | 2,174,745 | 3.04% | $6.15M | +390,751 | 0.00% |
| Two Sigma Investments, LP | 1,873,293 | 2.62% | $5.30M | −174,083 | 0.00% |
| Wasatch Advisors LP | 1,577,847 | 2.20% | $4.47M | – | 0.03% |
| Acadian Asset Management LLC | 1,360,548 | 1.90% | $3.85M | +100,772 | 0.00% |
| State Street Corp | 1,286,109 | 1.80% | $3.64M | +48,635 | 0.00% |
| Geode Capital Management, LLC | 1,285,507 | 1.79% | $3.64M | +17,592 | 0.00% |
| Renaissance Technologies LLC | 1,177,652 | 1.64% | $3.33M | −554,720 | 0.00% |
| Aqr Capital Management LLC | 1,054,251 | 1.47% | $2.98M | +458,525 | 0.00% |
| AWM Investment Company, Inc. | 906,000 | 1.26% | $2.56M | – | 0.22% |
| Blackstone Inc. | 747,044 | 1.04% | $2.11M | New | 0.01% |
| Marshall Wace, Llp | 673,010 | 0.94% | $1.90M | New | 0.00% |
| Panagora Asset Management Inc | 583,249 | 0.81% | $1.65M | +299,039 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 136 | 59M | 82.9% | 26 / 52 | 36 / 13 | 7M | 5M |
| Q1 2026 | 126 | 58M | 80.6% | 19 / 49 | 30 / 11 | 7M | 3M |
| Q4 2025 | 119 | 56M | 78.1% | 15 / 34 | 41 / 12 | 8M | 10M |
| Q3 2025 | 120 | 58M | 81.3% | 24 / 29 | 42 / 8 | 4M | 4M |
| Q2 2025 | 104 | 59M | 82.1% | 8 / 38 | 32 / 15 | 2M | 5M |
| Q1 2025 | 111 | 62M | 85.9% | 18 / 39 | 29 / 18 | 10M | 10M |
| Q4 2024 | 112 | 62M | 86.8% | 23 / 46 | 19 / 29 | 12M | 18M |
| Q3 2024 | 119 | 68M | 94.7% | 21 / 40 | 29 / 13 | 10M | 5M |
| Q2 2024 | 112 | 67M | 92.9% | 25 / 52 | 18 / 28 | 11M | 9M |
| Q1 2024 | 115 | 64M | 89.7% | 37 / 34 | 32 / 15 | 25M | 3M |
| Q4 2023 | 94 | 41M | 57.9% | 26 / 27 | 26 / 16 | 14M | 9M |
| Q3 2023 | 85 | 36M | 50.9% | 11 / 22 | 30 / 21 | 3M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
113 funds held NKTX in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NKTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,567,021 | 2.19% | $4.43M | 0.00% | Jun 30, 2026 |
| Wasatch Ultra Growth Fund | 1,487,369 | 2.08% | $4.21M | 0.91% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,144,067 | 1.60% | $3.24M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 573,211 | 0.80% | $1.62M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 490,138 | 0.68% | $1.02M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 454,858 | 0.64% | $1.29M | 0.01% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 349,646 | 0.49% | $989.50K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 282,739 | 0.39% | $918.90K | 0.00% | May 31, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 265,981 | 0.37% | $752.73K | 0.01% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Growth Fund | 263,800 | 0.37% | $746.55K | 0.09% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 238,436 | 0.33% | $774.92K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 150,315 | 0.21% | $425.39K | 0.03% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 145,492 | 0.20% | $304.08K | 0.00% | Jul 31, 2026 |
| Ultra-Small Company Market Fund | 110,000 | 0.15% | $311.30K | 0.21% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 108,444 | 0.15% | $226.65K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul J. Hastings | Chief Executive Officer, Director | 390,247 | 0.54% | Jun 22, 2026 |
| Nadir Mahmood | President | 167,727 | 0.23% | Jan 20, 2026 |
| Shawn Marshall Rose | See Remarks | 70,000 | 0.10% | Jan 8, 2026 |
| Alicia J. Hager | Chief Legal Officer | 146,735 | 0.20% | Jan 17, 2025 |
| Ralph Brandenberger | Chief Technical Officer | 124,796 | 0.17% | Jan 17, 2025 |
| Alyssa Levin | See Remarks | 102,662 | 0.14% | Jan 17, 2025 |
| David Shook | See Remarks | 190,955 | 0.27% | Jan 17, 2025 |
| Capital Healthcare Fund LP RA | Director, 10% owner | – | – | Jun 11, 2026 |
| Zachary Scheiner | Director | – | – | Jun 11, 2026 |
| Leone D. Patterson | Director | – | – | Jun 11, 2026 |
| Angela Thedinga | Director | – | – | Jun 11, 2026 |
| George Vratsanos | Director | – | – | Jun 11, 2026 |
| Michael Dybbs | Director | – | – | Jun 11, 2026 |
| Rajeev M. Shah | Director, 10% owner | 7,805,129 | 10.90% | Jun 11, 2026 |
| Peter Kolchinsky | Director, 10% owner | – | – | Jun 11, 2026 |
| RA Capital Nexus Fund, L.P. | Director | – | – | Jun 11, 2026 |
| Ra Capital Management, L.P. | Director, 10% owner | 10,050,818 | 14.03% | Jun 11, 2026 |
| Simeon George | Director | 3,333,333 | 4.65% | Jun 11, 2026 |
| Ali Behbahani | Director | – | – | Jun 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Paul J. Hastings Chief Executive Officer, Director | Jun 18, 2026 | Sale | −1,776 | $2.71 | $4.81K | 390,247 |
| Nadir Mahmood President | Jan 15, 2026 | Sale | −5,649 | $2.07 | $11.69K | 167,727 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 15, 2026 | Sale | −26,046 | $2.07 | $53.92K | 390,023 |
| Nadir Mahmood President | Jan 6, 2026 | Award | +80,000 | – | – | 173,376 |
| Shawn Marshall Rose See Remarks | Jan 6, 2026 | Award | +70,000 | – | – | 70,000 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 6, 2026 | Award | +94,000 | – | – | 416,069 |
| Paul J. Hastings Chief Executive Officer, Director | Jun 18, 2025 | Sale | −1,790 | $1.79 | $3.20K | 320,069 |
| Alyssa Levin See Remarks | Jan 15, 2025 | Sale | −5,838 | $2.20 | $12.84K | 102,662 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 15, 2025 | Sale | −17,378 | $2.20 | $38.23K | 319,859 |
| Ralph Brandenberger Chief Technical Officer | Jan 15, 2025 | Sale | −7,447 | $2.20 | $16.38K | 124,796 |
| Alicia J. Hager Chief Legal Officer | Jan 15, 2025 | Sale | −9,584 | $2.20 | $21.08K | 146,735 |
| David Shook See Remarks | Jan 15, 2025 | Sale | −8,638 | $2.20 | $19.00K | 190,955 |
| Alicia J. Hager Chief Legal Officer | Jan 3, 2025 | Award | +52,500 | – | – | 156,319 |
| Alyssa Levin See Remarks | Jan 3, 2025 | Award | +52,500 | – | – | 108,500 |
| Nadir Mahmood President | Jan 3, 2025 | Award | +62,000 | – | – | 93,376 |
| Ralph Brandenberger Chief Technical Officer | Jan 3, 2025 | Award | +52,500 | – | – | 132,243 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 3, 2025 | Award | +94,500 | – | – | 337,237 |
| David Shook See Remarks | Jan 3, 2025 | Award | +59,000 | – | – | 199,593 |
| David Shook See Remarks | Aug 21, 2024 | Award | −1,352 | $5.11 | $6.91K | 138,593 |
| Alicia J. Hager Chief Legal Officer | Jul 16, 2024 | Sale(10b5-1 plan) | −3,396 | $8.00 | $27.17K | 103,819 |
| David Shook See Remarks | Jul 15, 2024 | Award | +23,421 | – | – | 139,945 |
| Ralph Brandenberger Chief Technical Officer | Jun 18, 2024 | Sale | −229 | $5.60 | $1.28K | 79,743 |
| David Shook Chief Medical Officer | Jun 18, 2024 | Sale | −456 | $5.60 | $2.55K | 116,524 |
| Paul J. Hastings Chief Executive Officer, Director | Jun 18, 2024 | Sale | −1,770 | $5.60 | $9.91K | 240,737 |
| James Trager Chief Scientific Officer | Jun 18, 2024 | Sale | −456 | $5.60 | $2.55K | 150,959 |
| Alicia J. Hager Chief Legal Officer | Jun 18, 2024 | Sale | −727 | $5.60 | $4.07K | 107,215 |
| Ra Capital Management, L.P. Director, 10% owner | Mar 27, 2024 | Buy | +3,000,000 | $10.00 | $30.00M | 10,050,818 |
| Simeon George Director | Mar 27, 2024 | Buy | +451,659 | $10.00 | $4.52M | 451,659 |
| Simeon George Director | Mar 27, 2024 | Buy | +1,548,341 | $10.00 | $15.48M | 1,548,341 |
| Paul J. Hastings Chief Executive Officer, Director | Mar 4, 2024 | Returned to company | −137,642 | $13.33 | $1.83M | 240,507 |
| Ralph Brandenberger Chief Technical Officer | Mar 1, 2024 | Option exercise | +2,955 | $3.89 | $11.49K | 88,339 |
| Ralph Brandenberger Chief Technical Officer | Mar 1, 2024 | Option exercise | +3,808 | $3.89 | $14.81K | 85,384 |
| Ralph Brandenberger Chief Technical Officer | Mar 1, 2024 | Sale(10b5-1 plan) | −8,367 | $12.51 | $104.67K | 79,972 |
| Paul J. Hastings Chief Executive Officer, Director | Mar 1, 2024 | Returned to company | −12,358 | $13.00 | $160.65K | 378,149 |
| James Trager Chief Scientific Officer | Feb 12, 2024 | Sale(10b5-1 plan) | −4,143 | $12.00 | $49.72K | 149,415 |
| James Trager Chief Scientific Officer | Jan 16, 2024 | Sale | −4,560 | $8.74 | $39.85K | 153,558 |
| David Shook Chief Medical Officer | Jan 16, 2024 | Sale | −3,552 | $8.74 | $31.04K | 114,980 |
| Ralph Brandenberger Chief Technical Officer | Jan 16, 2024 | Sale | −2,512 | $8.74 | $21.95K | 81,576 |
| Alicia J. Hager Chief Legal Officer | Jan 16, 2024 | Sale | −4,554 | $8.74 | $39.80K | 107,942 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 16, 2024 | Sale | −9,697 | $8.74 | $84.75K | 390,507 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 4, 2024 | Award | +85,000 | – | – | 400,204 |
| Ralph Brandenberger Chief Technical Officer | Jan 4, 2024 | Award | +56,000 | – | – | 84,088 |
| James Trager Chief Scientific Officer | Jan 4, 2024 | Award | +56,000 | – | – | 158,118 |
| Alyssa Levin See Remarks | Jan 4, 2024 | Award | +56,000 | – | – | 56,000 |
| David Shook Chief Medical Officer | Jan 4, 2024 | Award | +56,000 | – | – | 118,532 |
| Alicia J. Hager Chief Legal Officer | Jan 4, 2024 | Award | +56,000 | – | – | 112,496 |
| David Shook Chief Medical Officer | Aug 21, 2023 | Sale | −1,331 | $1.83 | $2.44K | 60,532 |
| Nadir Mahmood See Remarks | Jun 20, 2023 | Sale | −526 | $4.85 | $2.55K | 85,776 |
| James Trager Chief Scientific Officer | Jun 20, 2023 | Sale | −439 | $4.85 | $2.13K | 100,118 |
| Alicia J. Hager Chief Legal Officer | Jun 20, 2023 | Sale | −701 | $4.85 | $3.40K | 56,496 |
| Ralph Brandenberger Chief Technical Officer | Jun 20, 2023 | Sale | −221 | $4.85 | $1.07K | 28,088 |
| David Shook Chief Medical Officer | Jun 20, 2023 | Sale | −439 | $4.85 | $2.13K | 61,863 |
| Paul J. Hastings Chief Executive Officer, Director | Jun 20, 2023 | Sale | −1,704 | $4.85 | $8.26K | 313,402 |
| Alicia J. Hager Chief Legal Officer | Jan 17, 2023 | Sale | −1,103 | $5.49 | $6.06K | 57,197 |
| James Trager Chief Scientific Officer | Jan 17, 2023 | Sale | −1,115 | $5.49 | $6.12K | 98,557 |
| Ralph Brandenberger Chief Technical Officer | Jan 17, 2023 | Sale | −491 | $5.49 | $2.70K | 28,309 |
| Paul J. Hastings Chief Executive Officer, Director | Jan 17, 2023 | Sale | −3,691 | $5.49 | $20.26K | 313,106 |
| Nadir Mahmood See Remarks | Jan 17, 2023 | Sale | −1,122 | $5.49 | $6.16K | 84,302 |
| David Shook Chief Medical Officer | Jan 17, 2023 | Sale | −175 | $5.49 | $961 | 60,302 |
| Alicia J. Hager Chief Legal Officer | Jan 13, 2023 | Award | +37,500 | – | – | 58,300 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nkarta's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,800 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Alicia J. Hager Officer | Jul 16, 2024 | 3,396 | $23.84K | Jul 16, 2024 | Restricted Stock Units |
| Paul J. Hastings Officer | Mar 4, 2024 | 60,000 | $770.40K | Mar 4, 2024 | Previously Exercised Options |
| Paul J. Hastings Officer | Mar 1, 2024 | 120,000 | $1.45M | Mar 1, 2024 | Previously Exercised Options |
| Ralph Brandenberger Officer | Mar 1, 2024 | 8,367 | $101.07K | Mar 1, 2024 | Exercise of Stock Options |
| James Trager Officer | Feb 12, 2024 | 4,143 | $46.03K | Feb 12, 2024 | Restricted Stock Units |
See a number that looks wrong?